News

Filter

Current filters:

Eli Lilly

101 to 110 of 96546 results

Pfizer’s palbociclib gains FDA Priority Review

13-10-2014

Pfizer says that the New Drug Application for its investigational breast cancer treatment palbociclib…

OncologypalbociclibPfizerPharmaceuticalRegulationUSA

Stada Arz in-licenses teriparatide, expanding its biosimilars portfolio

Stada Arz in-licenses teriparatide, expanding its biosimilars portfolio

13-10-2014

German generic and branded drugmaker Stada Arzneimittel has in-licensed osteoporosis drug teriparatide,…

Anti-Arthritics/RheumaticsBiosimilarsEli LillyForsteoGenericsLicensingRichter-Helm BioTecSTADA Arzneimittelteriparatide

New Ph III data to support filing for AbbVie’s Humira in HS

13-10-2014

US pharma company AbbVie has reported new data with its mega blockbuster arthritis drug Humira (adalimumab)…

AbbVieAnti-Arthritics/RheumaticsDermatologicalsHumiraPharmaceuticalResearch

New study finds fewer drugs covered by USA’s Medicare

13-10-2014

An analysis of US government data on 2015 Medicare drug plans by HealthPocket has found that the average…

FinancialHealthcarePharmaceuticalUSA

Growth set to return to CIS by 2015 with Kazakhstan in the lead

Growth set to return to CIS by 2015 with Kazakhstan in the lead

13-10-2014

Growth is set to return to markets in the Commonwealth of Independent States between 2015 and 2019, according…

GenericsKazakhstanMarkets & MarketingPharmaceuticalRussiaUkraine

Shire awards 10,000 euros to ADHD patient groups

Shire awards 10,000 euros to ADHD patient groups

13-10-2014

Ireland-based pharma company Shire announced the winners of the 2014 Excellence in ADHD Patient Group…

Adderall XREuropeHealthcareIrelandNeurologicalPharmaceuticalShireVyvanse

FDA approves Eisai’s Akynzeo for CINV

13-10-2014

The US Food and Drug Administration has approved Japanese pharma major Eisai’s Akynzeo (netupitant…

AkynzeoEisaiHelsinnnetupitantOncologypalonosetronPharmaceuticalRegulationUSA

101 to 110 of 96546 results

Parexel

Parexel

Back to top